Wrap-up interview - Insights from REPRISE III, a significant step forward for TAVI

This video is offered by Boston


An increasingly proven re-positionable TAVI device offering a true alternative today? Join M. Götberg, T. Feldman and L. Sondergaard as they discuss emerging results from a recent key international trial underlining the safety, efficacy and non-inferiority of the Lotus valve in a high-risk population. Listen as they tease out the meaning behind these results concerning stroke, paravalvular leak and pacemaker use in high- and lower-risk groups. What are we seeing in the newer-generation Lotus device and what design enhancements are we looking for in the future? How important is experience in implantation techniques? What should we expect from upcoming trials? Watch now...